Showing 15 posts of 25 posts found.


Takeda: Dengue vaccine successful in long-term trials & set for global distribution

May 25, 2021
Manufacturing and Production EMA, Vaccine, dengue

Japanese pharma company Takeda has announced long-term safety and efficacy results for its dengue vaccine candidate, TAK-003, and has successfully …


Strong Phase 3 showing for Takeda’s dengue vaccine, but concerns remain over consistent coverage

November 7, 2019
Research and Development Takeda, dengue, pharma

Takeda has unveiled new data from its ongoing Phase 3 trial investigating the efficacy of its vaccine candidate TAK-003 in …

Sanofi’s Dengvaxia becomes first FDA-approved dengue vaccine, but with caveats…

May 2, 2019
Sales and Marketing FDA, Sanofi, dengue, dengvaxia, pharma

Sanofi has announced that the FDA has granted authorisation to its tetravalent vaccine Dengvaxia for prevention of dengue disease originating …

FDA advisory panel recommends Sanofi’s dengue vaccine in children, but rejects its use in adults

March 11, 2019
Sales and Marketing FDA, Sanofi, US, Vaccine, dengue, dengvaxia, pharma

Dengvaxia, Sanofi’s vaccine for dengue fever, has been burdened with further negative scrutiny after the FDA’s vaccine advisory panel passed …

Philippines Department of Justice recommends charges against six Sanofi officials

March 1, 2019
Medical Communications Philippines, Sanofi, dengue, dengvaxia, vaccines

The Philippine Justice Ministry has said it has found probably cause to charge officials working for French drugmaker Sanofi over …

Philippines’ FDA halts sales of Sanofi’s dengue vaccine

February 19, 2019
Manufacturing and Production, Sales and Marketing Philippines, Sanofi, dengue, dengvaxia, pharma

The marketing authorisation for Sanofi’s dengue vaccine Dengvaxia has been revoked in the Philippines after the country’s Food and Drug …


Diet drugs supress appetite in mosquitoes, study shows

February 11, 2019
Sales and Marketing Zika, dengue, infectuous diseases, malaria, mosquitoes

Scientists were able to supress mosquitoes appetites using diet drugs for humans, according to research published in the journal Cell. …


Takeda’s dengue vaccine proves efficacious in massive Phase 3 trial

January 30, 2019
Research and Development Dengue fever, TAK-003, Takeda, Vaccine, dengue, health, infectious diseases

Takeda’s dengue vaccine candidate TAK-003, has proved efficacious in preventing dengue fever in healthy children and adolescents in an ongoing …

Danger of Sanofi’s dengue vaccine confirmed in new study

June 14, 2018
Medical Communications, Research and Development Sanofi, biotech, dengue, dengvaxia, drugs, pharma, pharmaceutical

A study that thoroughly analyses the impact of Sanofi’s dengue vaccine has confirmed what was feared – children without prior …


Sanofi’s controversial dengue vaccine may still hit US market, despite Philippines disaster

March 7, 2018
Sales and Marketing FDA, Philippines, Sanofi, US, dengue, dengvaxia, pharma

Sanofi has revealed that the ongoing debacle in the Philippines concerning its dengue vaccine Dengvaxia has not deterred it from …

Philippines’ launches legal action after Sanofi refuses to refund over dengue vaccine damages

February 5, 2018
Sales and Marketing Philippines, Sanofi, dengue, dengvaxia, pharma

Sanofi has refused both requests from the Government of the Philippines to refund used doses of its Dengvaxia vaccine as …


Philippines’ Department of Health demands full refund of $70m Dengvaxia programme from Sanofi

January 30, 2018
Manufacturing and Production, Sales and Marketing Philippines, Sanofi, dengue, dengvaxia, pharma

In the latest development in Sanofi’s Philippines dengue vaccine scandal, the nation’s Department of Health has demanded that the French …


Philippines’ FDA suspends Dengvaxia marketing, Sanofi responds

January 5, 2018
Medical Communications, Sales and Marketing Philippines, Sanofi, dengue, dengvaxia, pharma

As the Dengvaxia scandal in the Philippines rolls into 2018, it emerges that the country’s Food and Drugs Administration has …


The race to find an effective dengue vaccine

December 4, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, biotech, dengue, drugs, pharma, pharmaceutical

Derek Wallace, Global Dengue Program Head at Takeda Vaccine Business Unit, discusses the recent Phase 2 results showing its vaccine …


Sanofi admits to dangers of its dengue vaccine

November 30, 2017
Sales and Marketing Sanofi, biotech, dengue, drugs, pharma, pharmaceutical

After analysing six years’ worth of data on its dengue vaccine, Dengvaxia, Sanofi contacted health authorities to tell them that …

Latest content